EMA — authorised 10 May 2019
- Marketing authorisation holder: TEVA BV
- Status: approved
EMA authorised Taxol on 10 May 2019
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. EMA authorised it on 10 May 2019.
TEVA BV holds the EU marketing authorisation.